Diabetics and multiple sclerosis patients could take their medicine via a capsule or a tablet instead of enduring multiple injections, because of a new development by a UT professor.
Biomedical engineering professor Nikolaos Peppas and other researchers created a gel-like material that could coat a capsule that would deliver protein-based medicine, such as insulin.
Diabetics, who usually inject themselves with insulin two to three times per day, could swallow a gel-coated capsule that would release insulin in their upper small intestine and allow it to enter the bloodstream. The gel will allow the insulin to withstand harsh acidic conditions in the stomach and travel to its final destination..........
For the full report please go to
MSRC: MS Research News : New Discoveries : Technology